Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen balance Sheet — Total assets ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets (DB)
Latest, Q2 2026
95,639
Period ended Jun 30, 2026
Change on a year earlier
+8.8%
87,897 in Q2 2025
History
63 quarters
Since Q4 2008
Sources
61
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Balance Sheet — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 95,639 | +8.8% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 92,504 | +3.5% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 90,586 | -1.4% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 90,141 | -0.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 87,897 | -3.3% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 89,367 | -3.9% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 91,839 | -5.5% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2024 | Sep 30, 2024 | 90,883 | +0.4% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 90,907 | +0.7% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 92,980 | +4.8% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 97,154 | +49.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | 90,534 | +42.1% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | 90,269 | +52.2% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 88,720 | +49.9% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 65,121 | +6.5% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2022 | Sep 30, 2022 | 63,700 | -2.0% | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | 59,294 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 59,196 | -5.3% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | 61,165 | -2.8% | Form 10-K (filed 2022-02-16) ↗ |
| Q3 2021 | Sep 30, 2021 | 64,993 | +0.6% | Form 10-Q (filed 2021-11-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 62,539 | +1.4% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | 62,948 | +5.4% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 64,637 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | 65,011 | +9.5% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 61,669 | -3.6% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 59,707 | -10.1% | Form 10-K (filed 2020-02-12) ↗ |
| Q2 2019 | Jun 30, 2019 | 59,373 | -12.3% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 63,997 | -10.1% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 66,416 | -16.9% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 67,333 | -16.2% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 67,684 | -15.0% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | 71,164 | -8.6% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | 79,954 | +3.0% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 80,331 | +2.8% | Form 10-Q (filed 2017-10-26) ↗ |
| Q2 2017 | Jun 30, 2017 | 79,587 | +5.5% | Form 10-Q (filed 2017-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | 77,862 | +3.7% | Form 10-Q (filed 2017-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | 77,626 | +8.6% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2016 | Sep 30, 2016 | 78,150 | +8.7% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 75,471 | +6.0% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2016 | Mar 31, 2016 | 75,116 | +8.9% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2015 | Dec 31, 2015 | 71,449 | +3.5% | Form 10-Q (filed 2016-05-02) ↗ |
| Q3 2015 | Sep 30, 2015 | 71,869 | +1.5% | Form 10-Q (filed 2015-11-02) ↗ |
| Q2 2015 | Jun 30, 2015 | 71,209 | +2.4% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 68,952 | +2.9% | Form 10-Q (filed 2015-04-27) ↗ |
| Q4 2014 | Dec 31, 2014 | 69,009 | +4.4% | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | 70,775 | +24.0% | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 69,534 | – | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 67,004 | +29.8% | Form 10-Q (filed 2014-04-30) ↗ |
| Q4 2013 | Dec 31, 2013 | 66,125 | +21.8% | Form 10-K (filed 2014-02-24) ↗ |
| Q3 2013 | Sep 30, 2013 | 57,073 | +2.9% | Form 10-Q (filed 2013-10-29) ↗ |
| Q1 2013 | Mar 31, 2013 | 51,640 | – | Form 10-Q (filed 2013-05-03) ↗ |
| Q4 2012 | Dec 31, 2012 | 54,298 | +11.1% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 55,448 | – | Form 10-Q (filed 2012-11-06) ↗ |
| Q4 2011 | Dec 31, 2011 | 48,871 | +12.4% | Form 10-K (filed 2012-02-29) ↗ |
| Q1 2011 | Mar 31, 2011 | 42,714 | +5.8% | Form 10-Q (filed 2011-05-10) ↗ |
| Q4 2010 | Dec 31, 2010 | 43,486 | +9.7% | Form 10-K (filed 2011-02-25) ↗ |
| Q3 2010 | Sep 30, 2010 | 43,534 | +6.3% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 40,800 | +5.0% | Form 10-Q (filed 2010-08-09) ↗ |
| Q1 2010 | Mar 31, 2010 | 40,366 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 39,629 | +8.8% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 40,940 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 38,840 | – | Form 10-Q (filed 2009-08-10) ↗ |
| Q4 2008 | Dec 31, 2008 | 36,427 | – | Form 10-Q (filed 2009-08-10) ↗ |
Breakdown
What makes up balance sheet — total assets ($m)
- Cash and cash equivalents ($M)13,989 · Q2 2026
- Marketable securities ($M)0 · Q4 2023
- Trade receivables, net ($M)10,227 · Q2 2026
- Inventories ($M)6,220 · Q2 2026
- Other current assets ($M)4,525 · Q2 2026
- Total current assets ($M)34,961 · Q2 2026
- Property, plant and equipment, gross ($M)–
- Accumulated depreciation ($M)-9,400 · Q2 2026
- Property, plant and equipment, net ($M)8,547 · Q2 2026
- Intangible assets, net ($M)20,487 · Q2 2026
- Goodwill ($M)18,668 · Q2 2026
- Operating lease right-of-use assets ($M)–
- Other noncurrent assets ($M)12,976 · Q2 2026
- Accounts payable ($M)2,865 · Q2 2026
- Accrued liabilities ($M)17,192 · Q2 2026
- Total current liabilities ($M)25,502 · Q2 2026
- Long-term debt ($M)51,859 · Q2 2026
- Operating lease liabilities ($M)–
- Deferred tax liabilities ($M)1,301 · Q2 2026
- Other noncurrent liabilities ($M)2,445 · Q2 2026
- Retained earnings (accumulated deficit) ($M)-22,275 · Q2 2026
- Accumulated other comprehensive income (loss) ($M)-119 · Q2 2026
- Total stockholders' equity ($M)11,688 · Q2 2026
- Total liabilities and stockholders' equity ($M)95,639 · Q2 2026
- Common shares outstanding at period end (M)541 · Q2 2026
Cite this data
StockData. (2026). Amgen Balance Sheet — Total assets ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_balance_sheet
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.